Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12619001700123Phase 4Completed
Phase 4, randomised, single-blind trial of rocuronium (2 arms), sponsored by Putz Laurie. Primary endpoint: Conversion from no-curare group to curare group. Started Nov 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12619001700123.